ID   PDE6B_HUMAN             Reviewed;         854 AA.
AC   P35913; B7Z9T9; E7ETT3; Q53XN5; Q9BWH5; Q9UD49;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   14-APR-2009, sequence version 2.
DT   12-APR-2017, entry version 176.
DE   RecName: Full=Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta;
DE            Short=GMP-PDE beta;
DE            EC=3.1.4.35;
DE   Flags: Precursor;
GN   Name=PDE6B; Synonyms=PDEB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1720239; DOI=10.1093/nar/19.22.6263;
RA   Weber B., Riess O., Hutchinson G., Collins C., Lin B., Kowbel D.,
RA   Andrew S., Schappert K.T., Hayden M.R.;
RT   "Genomic organization and complete sequence of the human gene encoding
RT   the beta-subunit of the cGMP phosphodiesterase and its localisation to
RT   4p16.3.";
RL   Nucleic Acids Res. 19:6263-6268(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ILE-320.
RC   TISSUE=Retinal rod cell;
RX   PubMed=1338685;
RA   Khramtsov N.V., Feshchenko E.A., Suslova V.A., Terpugov B.E.,
RA   Rakitina T.V., Atabekova N.V., Shmukler B.E., Lipkin V.M.;
RT   "Structural studies of cDNA and the gene for the beta-subunit of cGMP
RT   phosphodiesterase from human retina.";
RL   Bioorg. Khim. 18:1551-1554(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ILE-320.
RC   TISSUE=Retina;
RX   PubMed=1322354; DOI=10.1016/0888-7543(92)90144-H;
RA   Collins C., Hutchinson G., Kowbel D., Riess O., Weber B., Hayden M.R.;
RT   "The human beta-subunit of rod photoreceptor cGMP phosphodiesterase:
RT   complete retinal cDNA sequence and evidence for expression in brain.";
RL   Genomics 13:698-704(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Retina;
RX   PubMed=8394243; DOI=10.1016/0014-5793(93)81003-I;
RA   Khramtsov N.V., Feshchenko E.A., Suslova V.A., Shmukler B.E.,
RA   Terpugov B.E., Rakitina T.V., Atabekova N.V., Lipkin V.M.;
RT   "The human rod photoreceptor cGMP phosphodiesterase beta-subunit.
RT   Structural studies of its cDNA and gene.";
RL   FEBS Lett. 327:275-278(1993).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANTS
RP   ILE-320 AND ASP-654.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT
RP   ILE-320.
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANTS
RP   ILE-320 AND ASP-654.
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 197-297, AND VARIANT CSNBAD2
RP   ASN-258.
RX   PubMed=8075643; DOI=10.1038/ng0594-64;
RA   Gal A., Orth U., Baehr W., Schwinger E., Rosenberg T.;
RT   "Heterozygous missense mutation in the rod cGMP phosphodiesterase
RT   beta-subunit gene in autosomal dominant stationary night blindness.";
RL   Nat. Genet. 7:64-68(1994).
RN   [10]
RP   ERRATUM.
RX   PubMed=7951329;
RA   Gal A., Orth U., Baehr W., Schwinger E., Rosenberg T.;
RL   Nat. Genet. 7:551-551(1994).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 238-854, AND VARIANT ILE-320.
RC   TISSUE=Retinal rod cell;
RX   PubMed=8768262;
RA   Suslova V.A., Suslov O.N., Kim E.E., Lipkin V.M.;
RT   "Organization of the gene for the beta-subunit of human photoreceptor
RT   cyclic GMP phosphodiesterase.";
RL   Bioorg. Khim. 22:256-263(1996).
RN   [12]
RP   VARIANT RP40 TYR-557.
RX   PubMed=8394174; DOI=10.1038/ng0693-130;
RA   McLaughlin M.E., Sandberg M.A., Berson E.L., Dryja T.P.;
RT   "Recessive mutations in the gene encoding the beta-subunit of rod
RT   phosphodiesterase in patients with retinitis pigmentosa.";
RL   Nat. Genet. 4:130-134(1993).
RN   [13]
RP   VARIANT RP40 ASP-576.
RX   PubMed=8595886; DOI=10.1006/geno.1995.0001;
RA   Danciger M., Blaney J., Gao Y.Q., Zhao D.Y., Heckenlively J.R.,
RA   Jacobson S.G., Farber D.B.;
RT   "Mutations in the PDE6B gene in autosomal recessive retinitis
RT   pigmentosa.";
RL   Genomics 30:1-7(1995).
RN   [14]
RP   VARIANT RP40 HIS-228, AND VARIANTS LYS-166 AND HIS-212.
RX   PubMed=8698075; DOI=10.1006/exer.1996.0019;
RA   Gao Y.Q., Danciger M., Zhao D.Y., Blaney J., Piriev N.I., Shih J.,
RA   Jacobson S.G., Heckenlively J.H., Farber D.B.;
RT   "Screening of the PDE6B gene in patients with autosomal dominant
RT   retinitis pigmentosa.";
RL   Exp. Eye Res. 62:149-154(1996).
RN   [15]
RP   VARIANT RP40 ARG-699.
RX   PubMed=8557257; DOI=10.1007/BF00218829;
RA   Valverde D., Solans T., Grinberg D., Balcells S., Vilageliu L.,
RA   Bayes M., Chivelet P., Besmond C., Goossens M., Gonzalez-Duarte R.,
RA   Baiget M.;
RT   "A novel mutation in exon 17 of the beta-subunit of rod
RT   phosphodiesterase in two RP sisters of a consanguineous family.";
RL   Hum. Genet. 97:35-38(1996).
RN   [16]
RP   VARIANT RP40 GLN-552.
RX   PubMed=8956055; DOI=10.1002/humu.1380080403;
RA   Valverde D., Baiget M., Seminago R., del Rio E., Garcia-Sandoval B.,
RA   del Rio T., Bayes M., Balcells S., Martinez A., Grinberg D., Ayuso C.;
RT   "Identification of a novel R552Q mutation in exon 13 of the beta-
RT   subunit of rod phosphodiesterase gene in a Spanish family with
RT   autosomal recessive retinitis pigmentosa.";
RL   Hum. Mutat. 8:393-394(1996).
RN   [17]
RP   VARIANT RP40 ASN-535.
RX   PubMed=9543643; DOI=10.1076/ceyr.17.3.332.5214;
RA   Saga M., Mashima Y., Akeo K., Kudoh J., Oguchi Y., Shimizu N.;
RT   "A novel homozygous Ile535Asn mutation in the rod cGMP
RT   phosphodiesterase beta-subunit gene in two brothers of a Japanese
RT   family with autosomal recessive retinitis pigmentosa.";
RL   Curr. Eye Res. 17:332-335(1998).
RN   [18]
RP   VARIANTS RP40 HIS-100 AND ASN-776.
RX   PubMed=22334370; DOI=10.1002/humu.22045;
RA   Neveling K., Collin R.W., Gilissen C., van Huet R.A., Visser L.,
RA   Kwint M.P., Gijsen S.J., Zonneveld M.N., Wieskamp N., de Ligt J.,
RA   Siemiatkowska A.M., Hoefsloot L.H., Buckley M.F., Kellner U.,
RA   Branham K.E., den Hollander A.I., Hoischen A., Hoyng C.,
RA   Klevering B.J., van den Born L.I., Veltman J.A., Cremers F.P.,
RA   Scheffer H.;
RT   "Next-generation genetic testing for retinitis pigmentosa.";
RL   Hum. Mutat. 33:963-972(2012).
CC   -!- FUNCTION: This protein participates in processes of transmission
CC       and amplification of the visual signal. Necessary for the
CC       formation of a functional phosphodiesterase holoenzyme.
CC   -!- CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =
CC       guanosine 5'-phosphate.
CC   -!- COFACTOR:
CC       Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;
CC         Evidence={ECO:0000250};
CC       Note=Binds 2 divalent metal cations per subunit. Site 1 may
CC       preferentially bind zinc ions, while site 2 has a preference for
CC       magnesium and/or manganese ions. {ECO:0000250};
CC   -!- SUBUNIT: Oligomer composed of two catalytic chains (alpha and
CC       beta), an inhibitory chain (gamma) and the delta chain.
CC   -!- SUBCELLULAR LOCATION: Membrane; Lipid-anchor.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P35913-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P35913-2; Sequence=VSP_036884;
CC       Name=3;
CC         IsoId=P35913-3; Sequence=VSP_044919;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Retinitis pigmentosa 40 (RP40) [MIM:613801]: A retinal
CC       dystrophy belonging to the group of pigmentary retinopathies.
CC       Retinitis pigmentosa is characterized by retinal pigment deposits
CC       visible on fundus examination and primary loss of rod
CC       photoreceptor cells followed by secondary loss of cone
CC       photoreceptors. Patients typically have night vision blindness and
CC       loss of midperipheral visual field. As their condition progresses,
CC       they lose their far peripheral visual field and eventually central
CC       vision as well. {ECO:0000269|PubMed:22334370,
CC       ECO:0000269|PubMed:8394174, ECO:0000269|PubMed:8557257,
CC       ECO:0000269|PubMed:8595886, ECO:0000269|PubMed:8698075,
CC       ECO:0000269|PubMed:8956055, ECO:0000269|PubMed:9543643}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Night blindness, congenital stationary, autosomal
CC       dominant 2 (CSNBAD2) [MIM:163500]: A non-progressive retinal
CC       disorder characterized by impaired night vision, often associated
CC       with nystagmus and myopia. {ECO:0000269|PubMed:8075643}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterase
CC       family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Mutations of the PDE6A/B/G genes; Note=Retina
CC       International's Scientific Newsletter;
CC       URL="http://www.retina-international.org/files/sci-news/pdemut.htm";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X62692; CAA44569.1; -; Genomic_DNA.
DR   EMBL; X62693; CAA44569.1; JOINED; Genomic_DNA.
DR   EMBL; X62694; CAA44569.1; JOINED; Genomic_DNA.
DR   EMBL; X62695; CAA44569.1; JOINED; Genomic_DNA.
DR   EMBL; X66142; CAA46932.1; -; mRNA.
DR   EMBL; S41458; AAB22690.1; -; mRNA.
DR   EMBL; BT009794; AAP88796.1; -; mRNA.
DR   EMBL; AK316054; BAH14425.1; -; mRNA.
DR   EMBL; AC107464; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000249; AAH00249.1; -; mRNA.
DR   EMBL; X90587; CAA62215.1; -; Genomic_DNA.
DR   EMBL; X90588; CAA62215.1; JOINED; Genomic_DNA.
DR   EMBL; X90589; CAA62215.1; JOINED; Genomic_DNA.
DR   EMBL; X90590; CAA62215.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS33932.1; -. [P35913-1]
DR   CCDS; CCDS46993.1; -. [P35913-3]
DR   CCDS; CCDS54703.1; -. [P35913-2]
DR   PIR; A42828; A42828.
DR   RefSeq; NP_000274.2; NM_000283.3.
DR   RefSeq; NP_001138763.1; NM_001145291.1.
DR   RefSeq; NP_001138764.1; NM_001145292.1.
DR   RefSeq; XP_016863774.1; XM_017008285.1. [P35913-3]
DR   RefSeq; XP_016863775.1; XM_017008286.1. [P35913-3]
DR   UniGene; Hs.623810; -.
DR   UniGene; Hs.654544; -.
DR   ProteinModelPortal; P35913; -.
DR   BioGrid; 111184; 1.
DR   STRING; 9606.ENSP00000420295; -.
DR   BindingDB; P35913; -.
DR   ChEMBL; CHEMBL2363066; -.
DR   DrugBank; DB00201; Caffeine.
DR   iPTMnet; P35913; -.
DR   PhosphoSitePlus; P35913; -.
DR   BioMuta; PDE6B; -.
DR   DMDM; 226693550; -.
DR   PaxDb; P35913; -.
DR   PeptideAtlas; P35913; -.
DR   PRIDE; P35913; -.
DR   DNASU; 5158; -.
DR   Ensembl; ENST00000255622; ENSP00000255622; ENSG00000133256. [P35913-2]
DR   Ensembl; ENST00000429163; ENSP00000406334; ENSG00000133256. [P35913-3]
DR   Ensembl; ENST00000496514; ENSP00000420295; ENSG00000133256. [P35913-1]
DR   GeneID; 5158; -.
DR   KEGG; hsa:5158; -.
DR   UCSC; uc003gao.5; human. [P35913-1]
DR   CTD; 5158; -.
DR   DisGeNET; 5158; -.
DR   GeneCards; PDE6B; -.
DR   GeneReviews; PDE6B; -.
DR   H-InvDB; HIX0031458; -.
DR   H-InvDB; HIX0031649; -.
DR   HGNC; HGNC:8786; PDE6B.
DR   HPA; HPA054148; -.
DR   HPA; HPA059929; -.
DR   MalaCards; PDE6B; -.
DR   MIM; 163500; phenotype.
DR   MIM; 180072; gene.
DR   MIM; 613801; phenotype.
DR   neXtProt; NX_P35913; -.
DR   OpenTargets; ENSG00000133256; -.
DR   Orphanet; 215; Congenital stationary night blindness.
DR   Orphanet; 791; Retinitis pigmentosa.
DR   PharmGKB; PA33134; -.
DR   eggNOG; KOG3689; Eukaryota.
DR   eggNOG; ENOG410XRI7; LUCA.
DR   GeneTree; ENSGT00760000119066; -.
DR   HOGENOM; HOG000007069; -.
DR   HOVERGEN; HBG053539; -.
DR   KO; K13756; -.
DR   OMA; SWVEYLS; -.
DR   OrthoDB; EOG091G01RK; -.
DR   PhylomeDB; P35913; -.
DR   TreeFam; TF316499; -.
DR   Reactome; R-HSA-2485179; Activation of the phototransduction cascade.
DR   Reactome; R-HSA-2514859; Inactivation, recovery and regulation of the phototransduction cascade.
DR   Reactome; R-HSA-4086398; Ca2+ pathway.
DR   ChiTaRS; PDE6B; human.
DR   GeneWiki; PDE6B; -.
DR   GenomeRNAi; 5158; -.
DR   PRO; PR:P35913; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000133256; -.
DR   CleanEx; HS_PDE6B; -.
DR   ExpressionAtlas; P35913; baseline and differential.
DR   Genevisible; P35913; HS.
DR   GO; GO:0097381; C:photoreceptor disc membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0047555; F:3',5'-cyclic-GMP phosphodiesterase activity; IMP:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046037; P:GMP metabolic process; IMP:BHF-UCL.
DR   GO; GO:0007603; P:phototransduction, visible light; TAS:ProtInc.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; IMP:BHF-UCL.
DR   GO; GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0060041; P:retina development in camera-type eye; IEA:Ensembl.
DR   GO; GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   GO; GO:0007223; P:Wnt signaling pathway, calcium modulating pathway; TAS:Reactome.
DR   Gene3D; 1.10.1300.10; -; 1.
DR   Gene3D; 3.30.450.40; -; 2.
DR   InterPro; IPR003018; GAF.
DR   InterPro; IPR029016; GAF_dom-like.
DR   InterPro; IPR003607; HD/PDEase_dom.
DR   InterPro; IPR023088; PDEase.
DR   InterPro; IPR002073; PDEase_catalytic_dom.
DR   InterPro; IPR023174; PDEase_CS.
DR   Pfam; PF01590; GAF; 2.
DR   Pfam; PF00233; PDEase_I; 1.
DR   PRINTS; PR00387; PDIESTERASE1.
DR   SMART; SM00065; GAF; 2.
DR   SMART; SM00471; HDc; 1.
DR   SUPFAM; SSF55781; SSF55781; 3.
DR   PROSITE; PS00126; PDEASE_I; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; cGMP; Complete proteome;
KW   Congenital stationary night blindness; Disease mutation; Hydrolase;
KW   Lipoprotein; Membrane; Metal-binding; Polymorphism; Prenylation;
KW   Reference proteome; Repeat; Retinitis pigmentosa;
KW   Sensory transduction; Vision.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P23439}.
FT   CHAIN         2    851       Rod cGMP-specific 3',5'-cyclic
FT                                phosphodiesterase subunit beta.
FT                                /FTId=PRO_0000023348.
FT   PROPEP      852    854       Removed in mature form. {ECO:0000250}.
FT                                /FTId=PRO_0000023349.
FT   DOMAIN       71    220       GAF 1.
FT   DOMAIN      252    429       GAF 2.
FT   ACT_SITE    557    557       Proton donor. {ECO:0000250}.
FT   METAL       561    561       Divalent metal cation 1. {ECO:0000250}.
FT   METAL       597    597       Divalent metal cation 1. {ECO:0000250}.
FT   METAL       598    598       Divalent metal cation 1. {ECO:0000250}.
FT   METAL       598    598       Divalent metal cation 2. {ECO:0000250}.
FT   METAL       718    718       Divalent metal cation 1. {ECO:0000250}.
FT   LIPID       851    851       S-geranylgeranyl cysteine. {ECO:0000250}.
FT   VAR_SEQ       1    279       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044919.
FT   VAR_SEQ     835    835       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_036884.
FT   VARIANT      74     74       R -> C (in RP40; autosomal recessive;
FT                                dbSNP:rs144590560).
FT                                /FTId=VAR_009283.
FT   VARIANT     100    100       R -> H (in RP40; dbSNP:rs555600300).
FT                                {ECO:0000269|PubMed:22334370}.
FT                                /FTId=VAR_068361.
FT   VARIANT     166    166       E -> K (in dbSNP:rs115775983).
FT                                {ECO:0000269|PubMed:8698075}.
FT                                /FTId=VAR_009284.
FT   VARIANT     212    212       Y -> H (in dbSNP:rs551545798).
FT                                {ECO:0000269|PubMed:8698075}.
FT                                /FTId=VAR_009285.
FT   VARIANT     219    219       Y -> H (in RP40; autosomal recessive;
FT                                dbSNP:rs62295357).
FT                                /FTId=VAR_009286.
FT   VARIANT     228    228       L -> H (in RP40; autosomal recessive and
FT                                autosomal dominant).
FT                                {ECO:0000269|PubMed:8698075}.
FT                                /FTId=VAR_009287.
FT   VARIANT     228    228       L -> I (in dbSNP:rs201584824).
FT                                /FTId=VAR_009288.
FT   VARIANT     258    258       H -> N (in CSNBAD2; dbSNP:rs121918582).
FT                                {ECO:0000269|PubMed:8075643}.
FT                                /FTId=VAR_009289.
FT   VARIANT     320    320       V -> I (in dbSNP:rs10902758).
FT                                {ECO:0000269|PubMed:1322354,
FT                                ECO:0000269|PubMed:1338685,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:8768262,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_054868.
FT   VARIANT     527    527       L -> P (in RP40; autosomal recessive;
FT                                dbSNP:rs760766981).
FT                                /FTId=VAR_009290.
FT   VARIANT     535    535       I -> N (in RP40; autosomal recessive;
FT                                dbSNP:rs527236088).
FT                                {ECO:0000269|PubMed:9543643}.
FT                                /FTId=VAR_009291.
FT   VARIANT     552    552       R -> Q (in RP40; autosomal recessive;
FT                                dbSNP:rs751859807).
FT                                {ECO:0000269|PubMed:8956055}.
FT                                /FTId=VAR_009292.
FT   VARIANT     557    557       H -> Y (in RP40; autosomal dominant;
FT                                dbSNP:rs121918581).
FT                                {ECO:0000269|PubMed:8394174}.
FT                                /FTId=VAR_006050.
FT   VARIANT     576    576       G -> D (in RP40; autosomal recessive).
FT                                {ECO:0000269|PubMed:8595886}.
FT                                /FTId=VAR_006051.
FT   VARIANT     654    654       E -> D (in dbSNP:rs17849286).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_054869.
FT   VARIANT     699    699       L -> R (in RP40; autosomal recessive).
FT                                {ECO:0000269|PubMed:8557257}.
FT                                /FTId=VAR_006052.
FT   VARIANT     776    776       D -> N (in RP40; dbSNP:rs141563823).
FT                                {ECO:0000269|PubMed:22334370}.
FT                                /FTId=VAR_068362.
FT   VARIANT     854    854       L -> R (in RP40; autosomal recessive).
FT                                /FTId=VAR_009293.
FT   CONFLICT     33     35       AAA -> GRG (in Ref. 1; CAA44569, 2;
FT                                CAA46932 and 3; AAB22690). {ECO:0000305}.
FT   CONFLICT    315    315       K -> Q (in Ref. 1; CAA44569).
FT                                {ECO:0000305}.
FT   CONFLICT    320    320       V -> L (in Ref. 1; CAA44569).
FT                                {ECO:0000305}.
FT   CONFLICT    360    360       A -> R (in Ref. 1; CAA44569).
FT                                {ECO:0000305}.
FT   CONFLICT    698    698       Y -> I (in Ref. 1; CAA44569).
FT                                {ECO:0000305}.
SQ   SEQUENCE   854 AA;  98336 MW;  BB11A519BE88C9DF CRC64;
     MSLSEEQARS FLDQNPDFAR QYFGKKLSPE NVAAACEDGC PPDCDSLRDL CQVEESTALL
     ELVQDMQESI NMERVVFKVL RRLCTLLQAD RCSLFMYRQR NGVAELATRL FSVQPDSVLE
     DCLVPPDSEI VFPLDIGVVG HVAQTKKMVN VEDVAECPHF SSFADELTDY KTKNMLATPI
     MNGKDVVAVI MAVNKLNGPF FTSEDEDVFL KYLNFATLYL KIYHLSYLHN CETRRGQVLL
     WSANKVFEEL TDIERQFHKA FYTVRAYLNC ERYSVGLLDM TKEKEFFDVW SVLMGESQPY
     SGPRTPDGRE IVFYKVIDYV LHGKEEIKVI PTPSADHWAL ASGLPSYVAE SGFICNIMNA
     SADEMFKFQE GALDDSGWLI KNVLSMPIVN KKEEIVGVAT FYNRKDGKPF DEQDEVLMES
     LTQFLGWSVM NTDTYDKMNK LENRKDIAQD MVLYHVKCDR DEIQLILPTR ARLGKEPADC
     DEDELGEILK EELPGPTTFD IYEFHFSDLE CTELDLVKCG IQMYYELGVV RKFQIPQEVL
     VRFLFSISKG YRRITYHNWR HGFNVAQTMF TLLMTGKLKS YYTDLEAFAM VTAGLCHDID
     HRGTNNLYQM KSQNPLAKLH GSSILERHHL EFGKFLLSEE TLNIYQNLNR RQHEHVIHLM
     DIAIIATDLA LYFKKRAMFQ KIVDESKNYQ DKKSWVEYLS LETTRKEIVM AMMMTACDLS
     AITKPWEVQS KVALLVAAEF WEQGDLERTV LDQQPIPMMD RNKAAELPKL QVGFIDFVCT
     FVYKEFSRFH EEILPMFDRL QNNRKEWKAL ADEYEAKVKA LEEKEEEERV AAKKVGTEIC
     NGGPAPKSST CCIL
//
